Jesús Troya García

39PUBLICATIONS
261CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsAboriginal and Torres Strait Islander medicine and treatmentsBehavioural epidemiologyGene and molecular therapyTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jul 16, 2026
Effect of Non-nucleoside Resistance-Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights From the Real-World RELATIVITY Cohort.

|Apr 21, 2026
Effectiveness and Persistence of Long-Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort.

|Jan 25, 2026
Long-acting cabotegravir and rilpivirine in people with HIV and obesity: Real-world outcomes from the RELATIVITY cohort.

Jesús Troya, Rafael Mican, María José Galindo

|Oct 23, 2025
A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study).

Luis Buzón-Martín, Maria Luisa Montes, Roberto Pedrero

|Oct 21, 2025
Clinical outcomes of long-acting cabotegravir and rilpivirine in people with HIV aged 60 and older: Real-world data from the Spanish RELATIVITY cohort.

Jesús Troya, María Luisa Montes, María José Galindo

|Oct 10, 2025
Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study).

Sergio Serrano-Villar, Laura Martín-Pedraza, Juan Tiraboschi

Pageof 7

Frequent Collaborators

12 joint publications

Luis Buzón-Martín

7 joint publications

Carmen Hidalgo-Tenorio

6 joint publications

Roberto Pedrero-Tomé

6 joint publications

Jean-Laurent Casanova